Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 4Recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 424Neoplasms 283Carcinoma, Non-Small-Cell Lung 268Colorectal Neoplasms 233Prostatic Neoplasms 173Lung Neoplasms 172Carcinoma, Hepatocellular 157Stomach Neoplasms 127Leukemia, Myeloid, Acute 119Pancreatic Neoplasms 117Multiple Myeloma 106Recurrence 98Uterine Cervical Neoplasms 95Squamous Cell Carcinoma of Head and Neck 88Neoplasm Metastasis 87Rectal Neoplasms 86Ovarian Neoplasms 80Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 72Head and Neck Neoplasms 67Brain Neoplasms 67Esophageal Neoplasms 64Glioblastoma 63Endometrial Neoplasms 60Colonic Neoplasms 60Melanoma 57Hematologic Neoplasms 54Motor Activity 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Glioma 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Myeloid Malignancies × Clear all
NCT06917105 2025-04-08

Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies

Tongji Hospital

Phase 1/2 Not yet recruiting
45 enrolled

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡